Doximity (NYSE: DOCS) shifts top legal and compliance roles

Rhea-AI Filing Summary

Doximity, Inc. announced that its General Counsel, Corporate Secretary, and Chief Compliance Officer, Jennifer Chaloemtiarana, will step down from all three roles effective August 29, 2025, and John Vaughan will assume these positions on the same date.

Chaloemtiarana will continue with the company in an advisory capacity through November 17, 2025, after which she will receive post-employment payments and benefits under her August 10, 2020 offer letter referenced in a prior Form 10-Q filing.

0001516513FALSE00015165132025-08-132025-08-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________________________________________________________________________________________

FORM 8-K

_________________________________________________________________________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 13, 2025

_________________________________________________________________________________________________________________

Doximity, Inc.

(Exact Name of Registrant as Specified in Its Charter)

_________________________________________________________________________________________________________________

Delaware			001-40508			27-2485512
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)
500 3rd St. Suite 510 San Francisco, CA 94107 (Address of principal executive offices, including zip code)
(650) 549-4330 (Registrant's telephone number, including area code)

_______________________________________________________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A common stock, $0.001 par value per share

DOCS

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On August 13, 2025, Doximity determined that Jennifer Chaloemtiarana, its General Counsel, Corporate Secretary, and Chief Compliance Officer, will step down from those roles effective August 29, 2025. John Vaughan will assume all three positions on the same date. Ms. Chaloemtiarana will remain employed with the company in an advisory capacity through November 17, 2025, after which she will receive the post-employment payments and benefits outlined in her August 10, 2020 offer letter, previously filed on August 8, 2023 with Doximity’s quarterly report on Form 10-Q.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 15, 2025

			DOXIMITY, INC.
			By:			/s/ Anna Bryson
						Anna Bryson Chief Financial Officer

FAQ

What leadership change did Doximity (DOCS) disclose in this 8-K?

Doximity disclosed that its General Counsel, Corporate Secretary, and Chief Compliance Officer, Jennifer Chaloemtiarana, will step down and be succeeded by John Vaughan on August 29, 2025. This consolidates all three key legal and compliance roles under Vaughan going forward.

When will Doximitys current General Counsel officially leave her roles?

Jennifer Chaloemtiarana will step down as General Counsel, Corporate Secretary, and Chief Compliance Officer effective August 29, 2025. She will, however, remain employed in an advisory capacity until November 17, 2025, providing continuity during the leadership transition period.

Who is taking over the legal and compliance functions at Doximity (DOCS)?

John Vaughan will assume the roles of General Counsel, Corporate Secretary, and Chief Compliance Officer at Doximity effective August 29, 2025. He will take over all three positions previously held by Jennifer Chaloemtiarana, centralizing oversight of legal and compliance matters.

How long will Doximitys departing General Counsel remain in an advisory role?

Jennifer Chaloemtiarana will remain with Doximity in an advisory capacity through November 17, 2025. This period allows her to support the transition of responsibilities to John Vaughan and helps maintain stability in legal and compliance operations during the change.

What post-employment benefits will Doximitys departing General Counsel receive?

After November 17, 2025, Jennifer Chaloemtiarana will receive post-employment payments and benefits described in her August 10, 2020 offer letter. That offer letter was previously filed with Doximitys Form 10-Q, and governs her separation terms following the advisory period.